Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

This bill allows for Medicare coverage and payment for multi-cancer early detection screening tests that are approved by the Food and Drug Administration and that are used to screen for cancer across many cancer types, if the Centers for Medicare & Medicaid Services determines such coverage is appropriate.

Bill 118 HR 2407, also known as the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, is a piece of legislation introduced in the US Congress. The bill aims to expand Medicare coverage to include multi-cancer early detection screening tests for individuals who are at high risk of developing cancer.

The bill is named after Nancy Gardner Sewell, a prominent advocate for cancer research and early detection. The goal of the legislation is to improve access to life-saving screening tests for individuals who may be at risk for developing various types of cancer. By expanding Medicare coverage to include these tests, the bill seeks to ensure that individuals have access to the necessary screenings that can detect cancer at an early stage when it is most treatable.

The bill has received bipartisan support in Congress, with lawmakers recognizing the importance of early detection in improving cancer outcomes. If passed, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act would represent a significant step forward in the fight against cancer and in improving healthcare access for individuals at risk. Overall, the bill aims to expand Medicare coverage to include multi-cancer early detection screening tests, with the goal of improving access to life-saving screenings for individuals at high risk of developing cancer. The legislation has garnered bipartisan support in Congress and represents a significant effort to improve cancer outcomes and healthcare access for individuals in need.